Suchergebnisse - "Lederer, David J"

PubPharm (11)

1

Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma : VOYAGE Study

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Bacharier, L. | Guilbert, T. | Katelaris, C. | +13

2

Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma

enthalten in: Respiratory medicine | 2024

von Papi, A. | Castro, M. | Corren, J. | +13

3

Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION) : an open-label extension study

enthalten in: The Lancet. Respiratory medicine | 2024

von Bacharier, L. | Maspero, J. | Katelaris, C. | +38

4

Dupilumab leads to better-controlled asthma and quality of life in children : the VOYAGE study

enthalten in: The European respiratory journal | 2023

von Fiocchi, A. | Phipatanakul, W. | Zeiger, R. | +11

5

Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids dose

enthalten in: Allergy | 2023

von Pavord, I. | Bourdin, A. | Papi, A. | +11

6

Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2023

von Corren, J. | Hanania, N. | Busse, W. | +10

7

Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma

enthalten in: Allergy | 2023

von Papadopoulos, N. | Szefler, S. | Bacharier, L. | +13

8

Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2023

von Jackson, D. | Bacharier, L. | Phipatanakul, W. | +19

9

Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2023

von Hanania, N. | Castro, M. | Bateman, E. | +17

10

Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma : An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial

enthalten in: Chest | 2022

von Sher, L. | Wechsler, M. | Rabe, K. | +14

CommentIn: Chest. 2022 Jul;162(1):4-5. - PMID 35809937